BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29199015)

  • 1. Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
    Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
    Pathology; 2018 Jan; 50(1):60-73. PubMed ID: 29199015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
    Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
    Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
    Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
    Egevad L; Delahunt B; Srigley JR; Samaratunga H
    APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head to head: should the intraductal component of invasive prostate cancer be graded?
    Varma M; Epstein JI
    Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
    Varma M
    Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal carcinoma of the prostate: a critical re-appraisal.
    Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
    Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution, controversies and the future of prostate cancer grading.
    Egevad L; Delahunt B; Yaxley J; Samaratunga H
    Pathol Int; 2019 Feb; 69(2):55-66. PubMed ID: 30694570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
    Gottipati S; Warncke J; Vollmer R; Humphrey PA
    Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
    Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
    Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
    Delahunt B; Steigler A; Atkinson C; Christie D; Duchesne G; Egevad L; Joseph D; Kenwright DN; Matthews J; Murray JD; Oldmeadow C; Samaratunga H; Spry NA; Thunders MC; Hondermarck H; Denham JW
    Pathology; 2022 Feb; 54(1):49-54. PubMed ID: 34955242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.